Inactive Instrument
Isracann Biosciences Inc. Stock Canadian Securities Exchange
Stocks
IPOT
CA46501D1087
Pharmaceuticals
OTC Markets Traded| Market Cap | 6.06M 5.32M 4.9M 4.57M 8.61M 576M 8.79M 58.94M 22.84M 283M 22.77M 22.27M 985M | P/E 2021 |
-1.24x | P/E 2022 | -2.25x |
|---|---|---|---|---|---|
| Enterprise Value | 5.85M 5.14M 4.73M 4.41M 8.31M 556M 8.48M 56.86M 22.03M 273M 21.96M 21.49M 950M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
99.83% | Yield 2021 * |
-
| Yield 2022 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Ajay Kala
CEO | Chief Executive Officer | - | 2023-01-19 |
Yana Popova
DFI | Director of Finance/CFO | 44 | 2017-11-14 |
Bob Mehr
PRN | Corporate Officer/Principal | - | 2022-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Bromley
BRD | Director/Board Member | 36 | 2019-12-18 |
Yana Popova
BRD | Director/Board Member | 44 | 2017-11-14 |
George Vrabec
BRD | Director/Board Member | - | 2022-04-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 176 | |
| +1.27% | -1.15% | -14.02% | -8.59% | 12.44B | |
| +0.61% | -1.52% | -35.52% | -59.61% | 4.67B | |
| +1.50% | +1.63% | -11.97% | -13.86% | 4.29B | |
| +2.33% | -0.58% | +8.87% | -40.25% | 3.69B | |
| +2.98% | +1.48% | +14.90% | -14.61% | 3.68B | |
| +1.22% | -13.98% | -14.70% | -22.66% | 3.01B | |
| +2.80% | -1.95% | -13.10% | -6.27% | 2.91B | |
| +3.15% | -1.57% | -7.27% | -26.86% | 2.27B | |
| +3.04% | -0.25% | -11.91% | +24.35% | 1.61B | |
| Average | +1.89% | +0.49% | -9.41% | -18.71% | 4.28B | |
| Weighted average by Cap. | +1.78% | +0.97% | -10.95% | -19.58% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -25.16M -22.09M -20.33M -18.94M -35.73M -2.39B -36.45M -245M -94.74M -1.17B -94.45M -92.41M -4.09B | -4.69M -4.12M -3.79M -3.53M -6.67M -446M -6.8M -45.62M -17.67M -219M -17.62M -17.24M -762M |
| Net Debt | -1.96M -1.72M -1.58M -1.47M -2.78M -186M -2.84M -19.04M -7.38M -91.39M -7.35M -7.19M -318M | -214K -188K -173K -161K -304K -20.34M -310K -2.08M -806K -9.98M -803K -786K -34.75M |
Employees
-
Sector
Pharmaceuticals
